Cargando…
Update on the appropriate use of linezolid in clinical practice
Multi-antibiotic resistant Gram-positive cocci, which include Staphylococcus aureus, the coagulase-negative staphylococcal group, Enterococcus faecalis and Enterococcus faecium, and other streptococci, represent emerging pathogens especially in the setting of the immunocompromised, hospitalized pati...
Autor principal: | Manfredi, Roberto |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1936365/ https://www.ncbi.nlm.nih.gov/pubmed/18360656 |
Ejemplares similares
-
Clinical update on linezolid in the treatment of Gram-positive bacterial infections
por: Ager, Sally, et al.
Publicado: (2012) -
Linezolid Resistance in Staphylococci
por: Stefani, Stefania, et al.
Publicado: (2010) -
Clinical use of linezolid in periprosthetic joint infections – a systematic review
por: Theil, Christoph, et al.
Publicado: (2020) -
Mechanisms of Linezolid Resistance in Mycobacteria
por: Gan, Wei Chong, et al.
Publicado: (2023) -
Aducanumab: Appropriate Use Recommendations Update
por: Cummings, J., et al.
Publicado: (2022)